Authors/Disclosures
|
|
No disclosure on file |
|
Kelly Baldwin, MD
(Evangelical Community Hospital)
|
Dr. Baldwin has nothing to disclose. |
|
Kelly Baldwin, MD
(Evangelical Community Hospital)
|
Dr. Baldwin has nothing to disclose. |
|
|
No disclosure on file |
|
Alan R. Hirsch, MD, FACP
(Illinois Center for Neurologial and Behavioral Medicine, Ltd.)
|
Dr. Hirsch has nothing to disclose. |
|
|
No disclosure on file |
|
Jafar Kafaie, MD, PhD, FÂé¶¹´«Ã½Ó³»
(Saint Louis University)
|
Dr. Kafaie has nothing to disclose. |
|
Bradley Elder
|
Bradley Elder has nothing to disclose. |
|
|
No disclosure on file |
|
|
No disclosure on file |
|
|
No disclosure on file |
|
|
No disclosure on file |
|
Phioanh L. Nghiemphu, MD, FÂé¶¹´«Ã½Ó³»
(UCLA Neuro-Oncology)
|
Dr. Nghiemphu has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Simpson Healthcare. Dr. Nghiemphu has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Nghiemphu has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Springswork. Dr. Nghiemphu has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for CIRM. Dr. Nghiemphu has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Servier. Dr. Nghiemphu has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Springworks. The institution of Dr. Nghiemphu has received research support from Erasca. The institution of Dr. Nghiemphu has received research support from Springswork. The institution of Dr. Nghiemphu has received research support from Children's Tumor Foundation. The institution of Dr. Nghiemphu has received research support from NIH-NCI . The institution of Dr. Nghiemphu has received research support from DOD. The institution of Dr. Nghiemphu has received research support from GCAR. |
|
|
No disclosure on file |
|
|
No disclosure on file |
|
|
No disclosure on file |
|
|
No disclosure on file |
|
|
No disclosure on file |
|
|
No disclosure on file |
|
|
No disclosure on file |
|
Asha Das, MD, FÂé¶¹´«Ã½Ó³»
(Progenics Pharmaceuticals)
|
No disclosure on file |